Amgen Inc. Debt Instrument, Redemption Price, Percentage
Amgen Inc. (AMGN) reported Debt Instrument, Redemption Price, Percentage of 101.00% for the 1-month period ending 2014-05-31, per its 10-Q filed 2014-08-05.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentRedemptionPricePercentage · last filed 2014-08-05
- 2014-05-31: Debt Instrument, Redemption Price, Percentage 1 month 101.00%.
| Period end | Debt Instrument, Redemption Price, Percentage 1 month |
|---|---|
| 2014-05-31 | 101.00% 10-Q · filed 2014-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |